3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
23
INDUSTRY
8
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
2
Other hematologic neoplasm
1
Other
1
Head & Neck
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
83
Urinary Bladder Neoplasms
31
Carcinoma, Renal Cell
9
Carcinoma, Transitional Cell
8
Kidney Neoplasms
7
Recurrence
5
Prostatic Hyperplasia
5
Neoplasms
5
Disease
5
Testicular Neoplasms
3
Pain, Postoperative
3
Pain
3
Non-Muscle Invasive Bladder Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Anxiety Disorders
3
Sleep Initiation and Maintenance Disorders
2
Penile Neoplasms
2
Pancreatic Neoplasms
2
Motor Activity
2
Melanoma
2
Lymphoma
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma
2
Acute Kidney Injury
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vomiting
1
Uterine Cervical Neoplasms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Diabetes Mellitus
×
Genitourinary
×
Clear all
NCT04834089
2021-04-08
SOROCOV
Butantan Institute
Phase 1/2
Unknown
618 enrolled